These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30407890)

  • 1. Brimonidine tartrate for the treatment of glaucoma.
    Oh DJ; Chen JL; Vajaranant TS; Dikopf MS
    Expert Opin Pharmacother; 2019 Jan; 20(1):115-122. PubMed ID: 30407890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
    Cantor LB
    Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine.
    Bakheit AH; Alomar AM; Darwish H; Alkahtani HM
    Profiles Drug Subst Excip Relat Methodol; 2023; 48():1-37. PubMed ID: 37061271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.
    Adkins JC; Balfour JA
    Drugs Aging; 1998 Mar; 12(3):225-41. PubMed ID: 9534022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservative-free
    Duru Z; Ozsaygili C
    Cutan Ocul Toxicol; 2020 Mar; 39(1):21-24. PubMed ID: 31615279
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of brimonidine in children with glaucoma.
    Enyedi LB; Freedman SF
    J AAPOS; 2001 Oct; 5(5):281-4. PubMed ID: 11641636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
    Toris CB; Camras CB; Yablonski ME
    Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
    Lusthaus JA; Goldberg I
    Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension [corrected].
    Carlsson AM; Chauhan BC; Lee AA; Leblanc RP
    Am J Ophthalmol; 1999 Dec; 128(6):697-701. PubMed ID: 10612505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of brimonidine.
    Burke J; Schwartz M
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S9-18. PubMed ID: 8970245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and current applications of brimonidine.
    Fudemberg SJ; Batiste C; Katz LJ
    Expert Opin Drug Saf; 2008 Nov; 7(6):795-9. PubMed ID: 18983225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The ocular hypotensive effect and safety of 0.2% brimonidine].
    Yu M; Li Y; Ge J
    Yan Ke Xue Bao; 2001 Dec; 17(4):235-8. PubMed ID: 12567513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of 0.2% brimonidine for preventing intraocular pressure rise following argon laser trabeculoplasty.
    Ma YR; Lee BH; Yang KJ; Park YG
    Korean J Ophthalmol; 1999 Dec; 13(2):78-84. PubMed ID: 10761402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy.
    thoe Schwartzenberg GW; Buys YM
    Ophthalmology; 1999 Aug; 106(8):1616-20. PubMed ID: 10442912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.
    Stewart WC; Day DG; Stewart JA; Holmes KT; Leech JN; Rowan CT; Schwartz GF
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):557-64. PubMed ID: 11132902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
    Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
    Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
    Frampton JE
    Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent central nervous system depression in infants after the use of topical brimonidine.
    Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE
    Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.
    Barnebey HS; Robin AL; Zimmerman TJ; Morrison JC; Hersh SB; Lewis RA; Coleman AL; Cinotti DJ; Walt J; Chen KS
    Ophthalmology; 1993 Jul; 100(7):1083-8. PubMed ID: 8100625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.